Trials / Completed
CompletedNCT04074551
A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
A Randomized, Double-blinded, Multi-center, Phase III Study to Compare The Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-blinded, Multi-center, Phase III Study to Compare The Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 versus HCP1701 in Patients with Hypertension and Dyslipidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HCP1701 | HCP1701 |
| DRUG | Losartan | Losartan |
| DRUG | Amlodipine | Amlodipine |
| DRUG | Rosuvastatin and Ezetimibe | Rosuvastatin and Ezetimibe |
Timeline
- Start date
- 2019-07-16
- Primary completion
- 2020-03-17
- Completion
- 2020-03-17
- First posted
- 2019-08-30
- Last updated
- 2020-11-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04074551. Inclusion in this directory is not an endorsement.